Oestrogen (adjunct) versus placebo for women with schizophrenia.

To evaluate the clinical efficacy and safety of oestrogen as an adjunctive treatment versus placebo, in women with schizophrenia or schizophrenia-like illnesses.

This is a protocol.

Share/Save